247 related articles for article (PubMed ID: 15585272)
1. Development of functionalized superparamagnetic iron oxide nanoparticles for interaction with human cancer cells.
Petri-Fink A; Chastellain M; Juillerat-Jeanneret L; Ferrari A; Hofmann H
Biomaterials; 2005 May; 26(15):2685-94. PubMed ID: 15585272
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxicity suppression and cellular uptake enhancement of surface modified magnetic nanoparticles.
Gupta AK; Gupta M
Biomaterials; 2005 May; 26(13):1565-73. PubMed ID: 15522758
[TBL] [Abstract][Full Text] [Related]
3. Surface-functionalized ultrasmall superparamagnetic nanoparticles as magnetic delivery vectors for camptothecin.
Cengelli F; Grzyb JA; Montoro A; Hofmann H; Hanessian S; Juillerat-Jeanneret L
ChemMedChem; 2009 Jun; 4(6):988-97. PubMed ID: 19347834
[TBL] [Abstract][Full Text] [Related]
4. Effect of cell media on polymer coated superparamagnetic iron oxide nanoparticles (SPIONs): colloidal stability, cytotoxicity, and cellular uptake studies.
Petri-Fink A; Steitz B; Finka A; Salaklang J; Hofmann H
Eur J Pharm Biopharm; 2008 Jan; 68(1):129-37. PubMed ID: 17881203
[TBL] [Abstract][Full Text] [Related]
5. Interaction of functionalized superparamagnetic iron oxide nanoparticles with brain structures.
Cengelli F; Maysinger D; Tschudi-Monnet F; Montet X; Corot C; Petri-Fink A; Hofmann H; Juillerat-Jeanneret L
J Pharmacol Exp Ther; 2006 Jul; 318(1):108-16. PubMed ID: 16608917
[TBL] [Abstract][Full Text] [Related]
6. Uptake and biocompatibility of functionalized poly(vinylalcohol) coated superparamagnetic maghemite nanoparticles by synoviocytes in vitro.
Schulze K; Koch A; Petri-Fink A; Steitz B; Kamau S; Hottiger M; Hilbe M; Vaughan L; Hofmann M; Hofmann H; von Rechenberg B
J Nanosci Nanotechnol; 2006; 6(9-10):2829-40. PubMed ID: 17048489
[TBL] [Abstract][Full Text] [Related]
7. Magnetic targeting after femoral artery administration and biocompatibility assessment of superparamagnetic iron oxide nanoparticles.
Ma HL; Qi XR; Ding WX; Maitani Y; Nagai T
J Biomed Mater Res A; 2008 Mar; 84(3):598-606. PubMed ID: 17618488
[TBL] [Abstract][Full Text] [Related]
8. Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs.
Win KY; Feng SS
Biomaterials; 2005 May; 26(15):2713-22. PubMed ID: 15585275
[TBL] [Abstract][Full Text] [Related]
9. Cell toxicity of superparamagnetic iron oxide nanoparticles.
Mahmoudi M; Simchi A; Milani AS; Stroeve P
J Colloid Interface Sci; 2009 Aug; 336(2):510-8. PubMed ID: 19476952
[TBL] [Abstract][Full Text] [Related]
10. Thermally cross-linked superparamagnetic iron oxide nanoparticles: synthesis and application as a dual imaging probe for cancer in vivo.
Lee H; Yu MK; Park S; Moon S; Min JJ; Jeong YY; Kang HW; Jon S
J Am Chem Soc; 2007 Oct; 129(42):12739-45. PubMed ID: 17892287
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications.
Gupta AK; Gupta M
Biomaterials; 2005 Jun; 26(18):3995-4021. PubMed ID: 15626447
[TBL] [Abstract][Full Text] [Related]
12. Preparation and characterization of superparamagnetic iron oxide nanoparticles stabilized by alginate.
Ma HL; Qi XR; Maitani Y; Nagai T
Int J Pharm; 2007 Mar; 333(1-2):177-86. PubMed ID: 17074454
[TBL] [Abstract][Full Text] [Related]
13. Integrin-targeting thermally cross-linked superparamagnetic iron oxide nanoparticles for combined cancer imaging and drug delivery.
Yu MK; Park J; Jeong YY; Moon WK; Jon S
Nanotechnology; 2010 Oct; 21(41):415102. PubMed ID: 20852354
[TBL] [Abstract][Full Text] [Related]
14. On the suitability of nanocrystalline ferrites as a magnetic carrier for drug delivery: functionalization, conjugation and drug release kinetics.
Rana S; Gallo A; Srivastava RS; Misra RD
Acta Biomater; 2007 Mar; 3(2):233-42. PubMed ID: 17224313
[TBL] [Abstract][Full Text] [Related]
15. Enhanced cell uptake of superparamagnetic iron oxide nanoparticles functionalized with dendritic guanidines.
Martin AL; Bernas LM; Rutt BK; Foster PJ; Gillies ER
Bioconjug Chem; 2008 Dec; 19(12):2375-84. PubMed ID: 19053308
[TBL] [Abstract][Full Text] [Related]
16. Fixed bed reactor for solid-phase surface derivatization of superparamagnetic nanoparticles.
Steitz B; Salaklang J; Finka A; O'Neil C; Hofmann H; Petri-Fink A
Bioconjug Chem; 2007; 18(5):1684-90. PubMed ID: 17718533
[TBL] [Abstract][Full Text] [Related]
17. Optimal design and characterization of superparamagnetic iron oxide nanoparticles coated with polyvinyl alcohol for targeted delivery and imaging.
Mahmoudi M; Simchi A; Imani M; Milani AS; Stroeve P
J Phys Chem B; 2008 Nov; 112(46):14470-81. PubMed ID: 18729404
[TBL] [Abstract][Full Text] [Related]
18. Interaction of cationic ultrasmall superparamagnetic iron oxide nanoparticles with human melanoma cells.
Cengelli F; Voinesco F; Juillerat-Jeanneret L
Nanomedicine (Lond); 2010 Sep; 5(7):1075-87. PubMed ID: 20874022
[TBL] [Abstract][Full Text] [Related]
19. Cellular level loading and heating of superparamagnetic iron oxide nanoparticles.
Kalambur VS; Longmire EK; Bischof JC
Langmuir; 2007 Nov; 23(24):12329-36. PubMed ID: 17960940
[TBL] [Abstract][Full Text] [Related]
20. Lactoferrin and ceruloplasmin derivatized superparamagnetic iron oxide nanoparticles for targeting cell surface receptors.
Gupta AK; Curtis AS
Biomaterials; 2004 Jul; 25(15):3029-40. PubMed ID: 14967536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
